Login / Signup

Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.

Jessica Pougoue KetchemenHanan BabekerAnjong Florence TikumAnand Krishnan NambisanFabrice Ngoh NjotuEmmanuel NwangeleHumphrey Fonge
Published in: British journal of cancer (2023)
Using these biologics simultaneously as biparatopic theranostic agents has additive benefits.
Keyphrases
  • photodynamic therapy
  • fluorescence imaging
  • iron oxide
  • drug induced
  • emergency department